SCHEMBL3846271

SCHEMBL3846271

N#Cc1cc(N2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)C6C=CC=CC6)c5)cc34)CC2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.40
CYP1A2 P05177 12/20 0.40
ALDH1A1 P00352 9/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 4/20 0.40
MEN1 O00255 7/20 0.38
KMT2A Q03164 7/20 0.38
LMNA P02545 6/20 0.38
HSD17B10 Q99714 3/20 0.38
MAPT P10636 1/20 0.38
CLK4 Q9HAZ1 7/20 0.37
HIF1A Q16665 7/20 0.37
USP2 O75604 5/20 0.37
CYP2D6 P10635 5/20 0.34
MAPK1 P28482 5/20 0.34
TSHR P16473 5/20 0.34
CYP2C19 P33261 4/20 0.34
SLC2A1 P11166 3/20 0.33
SLC2A2 P11168 3/20 0.33
SLC2A3 P11169 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846738 0.88 ACHE (0.39) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3845846 0.86 PHGDH (0.41) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3846270 0.86 CYP3A4 (0.47) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3847124 0.85 MAPT (0.42) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3853440 0.83 CYP3A4 (0.37) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3846797 0.83 CYP3A4 (0.49) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3847516 0.81 CYP3A4 (0.36) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3852228 0.81 CYP3A4 (0.36) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL4716053 0.80 CNR1 (0.38) CYP3A4CYP1A2ALDH1A1HPGDKDM4E
SCHEMBL3845654 0.76 ACHE (0.38) CYP3A4CYP1A2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed